-
Mashup Score: 1CDER Center for Clinical Trial Innovation (C3TI) - 10 day(s) ago
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration
Source: www.fda.govCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 2
A centrally led implementation strategy with local site tailoring led to faster delivery of tPA across disparate EDs in a multihospital system with no change in clinical effectiveness outcomes including rates of complication. Disparities in performance persisted between stroke and nonstroke centers.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 13Vitamin E Acetate is Associated with Select Proinflammatory Cytokines: An Analysis of a 2020-2022 Cohort of EVALI Patients - PubMed - 1 month(s) ago
Vitamin E Acetate is Associated with Select Proinflammatory Cytokines: An Analysis of a 2020-2022 Cohort of EVALI Patients
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 4
Rationale: It is unclear whether extracorporeal CO2 removal (ECCO2R) can reduce the rate of intubation or the total time on invasive mechanical ventilation (IMV) in adults experiencing an exacerbation of chronic obstructive pulmonary disease (COPD). Objectives: To …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 0Sign On - 2 month(s) ago
Sign on Using …
Source: wd5.myworkday.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 0
“NYC Health + Hospitals joins NYC and its department of education in a lawsuit against social media giants, alleging they have caused a youth mental health cris
Source: www.beckershospitalreview.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 16
Program: Oral and Poster Abstracts Session: 721. Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities: Poster II Hematology Disease Topics & Pathways: Lymphoid Leukemias, ALL, Acute Myeloid Malignancies, AML, Biological therapies, pediatric, Diseases, Therapies, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Transplantation, Minimal Residual Disease Christopher C Dvorak, MD 1, Lucia Holbrook-Brown 2 *, Janel R. Long-Boyle, PhD, PharmD 3 *, Hisham
Source: ash.confex.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 3NOT-GM-24-018: NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis Phenotyping (APS) Consortium - 4 month(s) ago
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis Phenotyping (APS) Consortium NOT-GM-24-018. NIGMS
Source: grants.nih.govCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 0Higher-Dose Ivermectin vs Placebo and Time to Sustained Recovery in Outpatients With COVID-19 - 4 month(s) ago
This platform randomized clinical trial examines the effectiveness of ivermectin at a targeted dose of 600 μg/kg daily compared with placebo for the treatment of early mild to moderate COVID-19.
Source: jamanetwork.comCategories: General Medicine News, Critical CareTweet
-
Mashup Score: 5Acute and Infectious Lung Diseases Branch | NHLBI, NIH - 5 month(s) ago
Official websites use .gov A.gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. The Acute and Infectious Lung Diseases Branch supports research and research training in acute lung injury, acute respiratory distress syndrome, critical care, pneumonia, sepsis, mechanical ventilation, lung transplantation, HIV/AIDS,
Source: www.nhlbi.nih.govCategories: General Medicine News, Critical CareTweet
This is, I think, an exciting opportunity for our trials community -- https://t.co/UDD6pVlF70 It will take ongoing careful input from key stakeholders and appears to be a great start.